Top compounds associated with response to OR5M8


Feature Type Standardized
Nominal ANOVA
mRNA PRIMA-1-Met CTRPv2 pan-cancer AAC -0.058 0.3
mRNA Sunitinib GDSC1000 pan-cancer AAC 0.057 0.3
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.039 0.3
mRNA Axitinib GDSC1000 pan-cancer AAC -0.04 0.3
mRNA Gefitinib CTRPv2 pan-cancer AAC -0.039 0.3
mRNA ML258 CTRPv2 pan-cancer AAC -0.04 0.3
mRNA carboplatin:etoposide (40:17 mol/mol) CTRPv2 pan-cancer AAC -0.032 0.3
mRNA tacrolimus CTRPv2 pan-cancer AAC -0.038 0.3
mRNA BRD-K58730230 CTRPv2 pan-cancer AAC 0.079 0.3
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC -0.036 0.3
Download CSV